Regeneron COVID-19 Therapeutic, Novavax Vaccine Get BARDA Funding To Boost Manufacturing

 
• By Brenda Sandburg

US government to own doses of Regeneron's investigational cocktail antibody REGN-COV2 manufactured under a $450m contract and 100 million doses of Novavax's investigational vaccine under a $1.6bn agreement.

Manufacturing and Covid-19 virus, symbolized by viruses destroying word Manufacturing to picture that coronavirus outbreak destroys Manufacturing, blurred background, 3d illustration
Government Funds Manufacturing Of COVID-19 Therapeutic And Vaccine • Source: Shutterstock

More from Manufacturing

More from Compliance